Animals, including humans, require a highly coordinated and flexible system of social
behavior and threat evaluation. However, trauma can disrupt this system, with the amygdala …

Schizophrenia is a severe mental illness that causes major functional impairment. Current
pharmacologic treatments are inadequate, particularly for addressing negative and cognitive …

Mutations in the synaptic gene SHANK3 lead to a neurodevelopmental disorder known as
Phelan-McDermid syndrome (PMS). PMS is a relatively common monogenic and highly …

The prosocial hormone oxytocin (OXT) has become a new target for research on the etiology
and treatment of autism spectrum disorder (ASD), a condition characterized by deficits in …

Neurodevelopmental disorders result from impaired development or maturation of the
central nervous system. Both genetic and environmental factors can contribute to the …

Intranasal oxytocin (IN OXT) administration has been proposed as a pharmacological
treatment for a range of biomedical conditions including neurodevelopmental disorders …

Given the prevalence and societal impact of autism spectrum disorders (ASD), there is an
urgent need to develop innovative preventative strategies and treatments to reduce the …

Rationale Exogenous oxytocin administration is widely reported to improve social cognition
in human and nonhuman primate adults. Risk factors of impaired social cognition, however …

Remote eye tracking with automated corneal reflection provides insights into the emergence
and development of cognitive, social, and emotional functions in human infants and non …

In humans, infants respond positively to slow, gentle stroking—processed by C-tactile (CT)
nerve fibers—by showing reductions in stress and increases in eye contact, smiling, and …